Brief: Redcare Pharmacy Group Sales Up 67% To EUR 476 Mln In Q3

Redcare Pharmacy NV

31/10/2023 05:34

Oct 31 (Reuters) - REDCARE PHARMACY NV  RDC.DE :
    * CONTINUED VERY FAST GROWTH COMBINED WITH MAJOR MARGIN
LIFT;
ADJUSTED. EBITDA 3.2% IN Q3, VERSUS. 0.4% LAST YEAR.
    * GROUP SALES UP 67% TO EUR 476M IN Q3 (9M UP 45% TO EUR
1.3BN).
    * ADJUSTED. EBITDA 3.2% IN Q3, VERSUS. 0.4% LAST YEAR.
    * NON-RX SALES GROWTH 27% IN Q3 TO EUR 319M (9M UP 26% TO
EUR
979M)
    * ADJUSTED. EBITDA MARGIN 3.2% IN Q3 (9M 2.9%, UP 4PP
VERSUS. LAST
YEAR'S 9M OF -1%; DRIVEN BY IMPROVEMENTS ACROSS BUSINESS).
    * ACTIVE CUSTOMERS 10.5M, UP 1.6M VERSUS. LAST YEAR.
    * CONFIRMATION OF PREVIOUSLY (1 AUGUST) RAISED FULL-YEAR
GUIDANCE.
    * YEAR TO DATE, GROUP'S GROSS PROFIT INCREASED TO EUR 319
MILLION
(9M 2022: EUR 240 MILLION)
    * 9M GROSS PROFIT MARGIN OVER SAME PERIOD WAS 25.2% COMPARED
TO
27.4% PREVIOUS YEAR
    * CASH BALANCE AT END OF REPORTING PERIOD WAS EUR 226
MILLION, UP
FROM EUR 180 AT 31 DECEMBER 2022

Source text for Eikon:  ID:nEQ6Z3k67a 
Further company coverage:  RDC.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))